Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Integrative Liver-Targeted Therapy for Diabetic Macular Edema: Combining Tauroursodeoxycholate and Traditional Chinese Medicine.

NCT07457632 is registered in ClinicalTrials.gov with University of Alabama at Birmingham as lead sponsor.

NCT NCT07457632
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07457632 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Integrative Liver-Targeted Therapy for Diabetic Macular Edema: Combining Tauroursodeoxycholate and Traditional Chinese Medicine.
Lead sponsor
University of Alabama at Birmingham
Phase
Phase 2
Overall status
Withdrawn
Start date
October 1, 2026
Completion date
December 31, 2028
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic macular edema (dme)